Diffusion Pharmaceuticals, Inc. (DFFN) Stock Undergoes Minor Volatility Ahead of TCOM Trial Findings
Diffusion Pharmaceuticals, Inc. (DFFN) stock prices were down by 3.33% as of the market closing on June 29th, 2021, bringing the price per share down